Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Dexamethasone Routes in Lower Third Molar Surgery
2024-517000-11-00Phase 4Authorised
- Sponsor
- Complutense University of Madrid
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in impacted third molar (I3M) (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: One year follow-up. Planned start Mar 2025; status: authorised.
02
Drugs
dexamethasone
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on 2024-517000-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517000-11-00.